Alpha 1 Antitrypsin Deficiency Clinical Trial
Official title:
Alpha-1 Foundation DNA and Tissue Bank
This is a long-term follow-up banking protocol that collects medical information and tissue (blood, liver and lung) samples for future research; use of data and samples for research purposes is overseen by the Tissue Bank Advisory Committee; the purpose of the Bank is to further research on alpha-1 antitrypsin deficiency.
Subject participation includes completion of informed consent, medical questionnaire, and email authorization. Subjects may provide a blood sample for alpha-1 antitrypsin genotype, phenotype and level. Lung and liver tissue may also be provided if available. Subjects may be contacted no more often than annually for updated information. This project has a certificate of confidentiality from NIH. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01832220 -
Genomic Research in Alpha-1 Antitrypsin Deficiency
|
N/A | |
| Completed |
NCT01669421 -
Effect of Double Dose of Alpha 1-antitrypsin Augmentation Therapy on Lung Inflammation.
|
Phase 2 |